Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo

被引:14
|
作者
Lee, M. K. [1 ]
Tong, W. M. [2 ]
Wang, Z. Q. [3 ,4 ]
Sabapathy, K. [1 ,5 ,6 ]
机构
[1] Natl Canc Ctr, Mol Carcinogenesis Lab, Div Cellular & Mol Res, Humphrey Oei Inst Canc Res, Singapore 169610, Singapore
[2] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll, Beijing 100037, Peoples R China
[3] Fritz Lipmann Inst eV, Leibniz Inst Age Res, D-07745 Jena, Germany
[4] Friedrich Schiller Univ, Biol & Pharm Fac, D-07745 Jena, Germany
[5] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore
[6] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore
来源
CELL DEATH AND DIFFERENTIATION | 2011年 / 18卷 / 02期
基金
英国医学研究理事会;
关键词
ER-stress; p53; phosphorylation; protein stability; S312; EMBRYONIC STEM-CELLS; DNA-DAMAGE; TUMOR-SUPPRESSOR; POINT MUTATION; MOUSE MODELS; MDM2; DEGRADATION; APOPTOSIS; MICE; TRANSCRIPTION;
D O I
10.1038/cdd.2010.90
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular stimulation results in phosphorylation of the tumor suppressor p53 on multiple residues, though the functional relevance is not always clear. It is noteworthy that the serine (S) 315 residue is unique, as it has been suggested to be phosphorylated not only by genotoxic signals, but also during cell-cycle progression and by endoplasmic-reticulum stress. However, in vitro data have been conflicting as phosphorylation at this site was shown to both positively and negatively regulate p53 functions. We have thus generated knock-in mice expressing an unphosphorylable S312 (equivalent to human S315), by substitution with an alanine (A) residue, to clarify the conflicting observations and to evaluate its functional relevance in vivo. Born at Mendelian ratios, the p53(S312A/S312A) mice show no anomalies during development and adulthood. p53 activation, stability, localization and ability to induce apoptosis, cell-cycle arrest and prevent centrosome amplification are not compromised in p53(S312A/S312A) cells. p53(S312A/S312A) mice are unable to rescue mdm2(-/-) lethality, and tumorigenesis - both spontaneous and irradiation/oncogene-induced - is not accentuated. Taken together, the results show that the S312 phosphorylation site is not in itself necessary for efficient p53 function, and advocates the possibility that it is neither relevant in the mouse context nor important for p53 functions in vivo. Cell Death and Differentiation (2011) 18, 214-221; doi: 10.1038/cdd.2010.90; published online 30 July 2010
引用
收藏
页码:214 / 221
页数:8
相关论文
共 50 条
  • [21] Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo
    Slee, Elizabeth A.
    Benassi, Barbara
    Goldin, Robert
    Zhong, Shan
    Ratnayaka, Indrika
    Blandino, Giovanni
    Lu, Xin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (45) : 19479 - 19484
  • [22] Temperature sensitivity of human wild-type and mutant p53 proteins expressed in vivo
    F Ponchel
    J Milner
    British Journal of Cancer, 1998, 77 : 1555 - 1561
  • [23] Temperature sensitivity of human wild-type and mutant p53 proteins expressed in vivo
    Ponchel, F
    Milner, J
    BRITISH JOURNAL OF CANCER, 1998, 77 (10) : 1555 - 1561
  • [24] Insights into Wild-Type and Mutant p53 Functions Provided by Genetically Engineered Mice
    Donehower, Lawrence A.
    HUMAN MUTATION, 2014, 35 (06) : 715 - 727
  • [25] Phosphorylation of serine 18 regulates distinct p53 functions in mice
    Sluss, HK
    Armata, H
    Gallant, J
    Jones, SN
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) : 976 - 984
  • [26] Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
    M Szybka
    I Zawlik
    D Kulczycka
    E Golanska
    E Jesien
    D Kupnicka
    R Stawski
    S Piaskowski
    E Bieniek
    M Zakrzewska
    R Kordek
    P P Liberski
    P Rieske
    British Journal of Cancer, 2008, 98 : 1431 - 1433
  • [27] INACTIVE P53 MUTANTS MAY ENHANCE THE TRANSCRIPTIONAL ACTIVITY OF WILD-TYPE P53
    ZHANG, W
    SHAY, JW
    DEISSEROTH, A
    CANCER RESEARCH, 1993, 53 (20) : 4772 - 4775
  • [28] Mutant p53: Gain-of-function oncoproteins and wild-type p53 inactivators
    Roemer, K
    BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) : 879 - 887
  • [29] Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
    Szybka, M.
    Zawlik, I.
    Kulczycka, D.
    Golanska, E.
    Jesien, E.
    Kupnicka, D.
    Stawski, R.
    Piaskowski, S.
    Bieniek, E.
    Zakrzewska, M.
    Kordek, R.
    Liberski, P. P.
    Rieske, P.
    BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1431 - 1433
  • [30] Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK
    Wolf, Eric R.
    McAtarsney, Ciaran P.
    Bredhold, Kristin E.
    Kline, Amber M.
    Mayo, Lindsey D.
    SCIENCE SIGNALING, 2018, 11 (524)